This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Jul 19;316(3):277-9.

doi: 10.1001/jama.2016.8897.

Improving Outcomes for Persons With Opioid Use Disorders: Buprenorphine Implants to Improve Adherence and Access to Care

Wilson M Compton¹, Nora D Volkow¹

Affiliations

PMID: 27434440
DOI: 10.1001/jama.2016.8897

Editorial

Improving Outcomes for Persons With Opioid Use Disorders: Buprenorphine Implants to Improve Adherence and Access to Care

Wilson M Compton et al. JAMA. 2016.

. 2016 Jul 19;316(3):277-9.

doi: 10.1001/jama.2016.8897.

Authors

Wilson M Compton¹, Nora D Volkow¹

Affiliation

¹ National Institute on Drug Abuse, Bethesda, Maryland.

PMID: 27434440
DOI: 10.1001/jama.2016.8897

No abstract available

PubMed Disclaimer

Comment on

Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial.
Rosenthal RN, Lofwall MR, Kim S, Chen M, Beebe KL, Vocci FJ; PRO-814 Study Group. Rosenthal RN, et al. JAMA. 2016 Jul 19;316(3):282-90. doi: 10.1001/jama.2016.9382. JAMA. 2016. PMID: 27434441 Clinical Trial.

Similar articles

Buprenorphine implants and opioid dependence.
Rastegar DA. Rastegar DA. JAMA. 2011 Jan 19;305(3):253; author reply 254-5. doi: 10.1001/jama.2010.1988. JAMA. 2011. PMID: 21245178 No abstract available.
Buprenorphine implants and opioid dependence.
Basu D, Kumar V. Basu D, et al. JAMA. 2011 Jan 19;305(3):253-4; author reply 254. doi: 10.1001/jama.2010.1989. JAMA. 2011. PMID: 21245177 No abstract available.
Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial.
Ling W, Casadonte P, Bigelow G, Kampman KM, Patkar A, Bailey GL, Rosenthal RN, Beebe KL. Ling W, et al. JAMA. 2010 Oct 13;304(14):1576-83. doi: 10.1001/jama.2010.1427. JAMA. 2010. PMID: 20940383 Clinical Trial.
Anesthesia for patients on buprenorphine.
Bryson EO, Lipson S, Gevirtz C. Bryson EO, et al. Anesthesiol Clin. 2010 Dec;28(4):611-7. doi: 10.1016/j.anclin.2010.08.005. Anesthesiol Clin. 2010. PMID: 21074741 Review.
Managing Opioid Withdrawal in the Emergency Department With Buprenorphine.
Herring AA, Perrone J, Nelson LS. Herring AA, et al. Ann Emerg Med. 2019 May;73(5):481-487. doi: 10.1016/j.annemergmed.2018.11.032. Epub 2019 Jan 5. Ann Emerg Med. 2019. PMID: 30616926 Review. No abstract available.

See all similar articles

Cited by

Inbred rat heredity and sex affect oral oxycodone self-administration and augmented intake in long sessions: correlations with anxiety and novelty-seeking.
Sharp BM, Leng S, Huang J, Jones C, Chen H. Sharp BM, et al. bioRxiv [Preprint]. 2024 May 29:2023.11.26.568753. doi: 10.1101/2023.11.26.568753. bioRxiv. 2024. PMID: 38076806 Free PMC article. Preprint.
Sex and heredity are determinants of drug intake in a novel model of rat oral oxycodone self-administration.
Sharp BM, Fan X, Redei EE, Mulligan MK, Chen H. Sharp BM, et al. Genes Brain Behav. 2021 Nov;20(8):e12770. doi: 10.1111/gbb.12770. Epub 2021 Sep 16. Genes Brain Behav. 2021. PMID: 34459088 Free PMC article.
Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations.
Winhusen T, Lofwall M, Jones HE, Wilder C, Lindblad R, Schiff DM, Wexelblatt S, Merhar S, Murphy SM, Greenfield SF, Terplan M, Wachman EM, Kropp F, Theobald J, Lewis M, Matthews AG, Guille C, Silverstein M, Rosa C. Winhusen T, et al. Contemp Clin Trials. 2020 Jun;93:106014. doi: 10.1016/j.cct.2020.106014. Epub 2020 Apr 27. Contemp Clin Trials. 2020. PMID: 32353544 Free PMC article.
Electrostatically gated nanofluidic membrane for ultra-low power controlled drug delivery.
Di Trani N, Silvestri A, Sizovs A, Wang Y, Erm DR, Demarchi D, Liu X, Grattoni A. Di Trani N, et al. Lab Chip. 2020 May 5;20(9):1562-1576. doi: 10.1039/d0lc00121j. Lab Chip. 2020. PMID: 32249279 Free PMC article.
Advances in the delivery of buprenorphine for opioid dependence.
Rosenthal RN, Goradia VV. Rosenthal RN, et al. Drug Des Devel Ther. 2017 Aug 28;11:2493-2505. doi: 10.2147/DDDT.S72543. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28894357 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information